232 related articles for article (PubMed ID: 33451088)
1. Memory Enhancers for Alzheimer's Dementia: Focus on cGMP.
Fedele E; Ricciarelli R
Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33451088
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.
Domek-Łopacińska KU; Strosznajder JB
Mol Neurobiol; 2010 Jun; 41(2-3):129-37. PubMed ID: 20213343
[TBL] [Abstract][Full Text] [Related]
3. NO/cGMP-dependent modulation of synaptic transmission.
Feil R; Kleppisch T
Handb Exp Pharmacol; 2008; (184):529-60. PubMed ID: 18064424
[TBL] [Abstract][Full Text] [Related]
4. The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents.
Rosenbrock H; Giovannini R; Schänzle G; Koros E; Runge F; Fuchs H; Marti A; Reymann KG; Schröder UH; Fedele E; Dorner-Ciossek C
J Pharmacol Exp Ther; 2019 Dec; 371(3):633-641. PubMed ID: 31578258
[No Abstract] [Full Text] [Related]
5. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour.
Kleppisch T; Feil R
Handb Exp Pharmacol; 2009; (191):549-79. PubMed ID: 19089345
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.
Sanders O; Rajagopal L
J Alzheimers Dis Rep; 2020 Jun; 4(1):185-215. PubMed ID: 32715279
[TBL] [Abstract][Full Text] [Related]
7. In Search of Enzymes with a Role in 3', 5'-Cyclic Guanosine Monophosphate Metabolism in Plants.
Gross I; Durner J
Front Plant Sci; 2016; 7():576. PubMed ID: 27200049
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
Lueptow LM; Zhan CG; O'Donnell JM
Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
[TBL] [Abstract][Full Text] [Related]
9. G-substrate: the cerebellum and beyond.
Endo S
Prog Mol Biol Transl Sci; 2012; 106():381-416. PubMed ID: 22340725
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP metabolism and its role in brain physiology.
Domek-Łopacińska K; Strosznajder JB
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
[TBL] [Abstract][Full Text] [Related]
11. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
12. Intracellular and extracelluar cyclic GMP in the brain and the hippocampus.
Taoro-González L; Cabrera-Pastor A; Sancho-Alonso M; Felipo V
Vitam Horm; 2022; 118():247-288. PubMed ID: 35180929
[TBL] [Abstract][Full Text] [Related]
13. Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide.
Sawa T; Ihara H; Ida T; Fujii S; Nishida M; Akaike T
Nitric Oxide; 2013 Nov; 34():10-8. PubMed ID: 23632125
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Neitz A; Mergia E; Eysel UT; Koesling D; Mittmann T
Eur J Neurosci; 2011 May; 33(9):1611-21. PubMed ID: 21410795
[TBL] [Abstract][Full Text] [Related]
15. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
16. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
Geng Y; Zhou L; Thompson WJ; Lotz M
J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylyl cyclase: more secrets revealed.
Pyriochou A; Papapetropoulos A
Cell Signal; 2005 Apr; 17(4):407-13. PubMed ID: 15601619
[TBL] [Abstract][Full Text] [Related]
18. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
19. NO-cGMP signaling and regenerative medicine involving stem cells.
Madhusoodanan KS; Murad F
Neurochem Res; 2007; 32(4-5):681-94. PubMed ID: 17043768
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
